Cargando…

Final Height and Endocrine Complications in Patients with β-Thalassemia Intermedia: Our Experience in Non-Transfused Versus Infrequently Transfused Patients and Correlations with Liver Iron Content

BACKGROUND: β-thalassemia intermedia (TI) spans a wide spectrum of severity and carries higher morbidity than previously recognized, including extramedullary hematopoiesis, leg ulcers, gallstones, thrombosis, secondary heart failure, pulmonary hypertension, skeletal deformity, growth retardation and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yassin, Mohamed A., Soliman, Ashraf T., De Sanctis, Vincenzo, Yassin, Khadra S., Abdulla, Mohammad AJ.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Università Cattolica del Sacro Cuore 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6548215/ https://www.ncbi.nlm.nih.gov/pubmed/31205630 http://dx.doi.org/10.4084/MJHID.2019.026

Ejemplares similares

Final adult height and endocrine complications in young adults with β-thalassemia major (TM) who received oral iron chelation (OIC) in comparison with those who did not use OIC
por: Soliman, Ashraf T, et al.
Publicado: (2018)

Marital status and paternity in patients with Transfusion-Dependent Thalassemia (TDT) and Non Transfusion-Dependent Thalassemia (NTDT): an ICET - A survey in different countries
por: De Sanctis, Vincenzo, et al.
Publicado: (2019)

A persistent cough as atypical clinical presentation of intrathoracic extramedullary hematopoiesis (EMH) in a female with thalassemia intermedia
por: Abdulla, Mohammad AJ, et al.
Publicado: (2018)

P1454: CLINICAL DETERMINANTS OF CARDIAC IRON IN REGULARLY TRANSFUSED THALASSEMIA INTERMEDIA PATIENTS
por: Meloni, Antonella, et al.
Publicado: (2023)

Endocrine Function in Thalassemia Intermedia
por: Karamifar, H., et al.
Publicado: (2006)

Detection of endocrine disorders in young children with multi-transfused thalassemia major
por: Mahmoud, Ramadan A., et al.
Publicado: (2021)

Blood transfusion among thalassemia patients: A single Egyptian center experience
por: Ragab, Lamis A., et al.
Publicado: (2013)

The experience of a tertiary unit on the clinical phenotype and management of hypogonadism in female adolescents and young adults with transfusion dependent thalassemia
por: Vincenzo, De Sanctis, et al.
Publicado: (2019)

Clinical characteristics, biochemical parameters and insulin response to oral glucose tolerance test (OGTT) in 25 transfusion dependent β-thalassemia (TDT) patients recently diagnosed with diabetes mellitus (DM)
por: de Sanctis, Vincenzo, et al.
Publicado: (2021)

Protocol for extramedullary hematopoiesis in patients with transfusion‐dependent β‐thalassemia (TDT): A systematic review
por: Ata, Fateen, et al.
Publicado: (2021)

Vitamin D Status in Thalassemia Major: an Update
por: Soliman, Ashraf, et al.
Publicado: (2013)

Blood transfusion and iron overload in patients with Sickle Cell Disease (SCD): Personal experience and a short update of diabetes mellitus occurrence
por: Soliman, Ashraf T, et al.
Publicado: (2022)

MRI prospective survey on cardiac and hepatic iron in transfusion-dependent thalassemia intermedia patients treated with desferrioxamine, deferiprone and deferasirox
por: Meloni, Antonella, et al.
Publicado: (2015)

Correlation of Serum Ferritin and Liver Iron Concentration with Transient Liver Elastography in Adult Thalassemia Intermedia Patients with Blood Transfusion
por: Atmakusuma, Tubagus Djumhana, et al.
Publicado: (2021)

Extramedullary haematopoiesis in patients with transfusion dependent β-thalassaemia (TDT): a systematic review
por: Subahi, Eihab A., et al.
Publicado: (2022)

Ocular abnormalities in patients with beta thalassemia on transfusion and chelation therapy: Our experience
por: Jethani, Jitendra, et al.
Publicado: (2010)

Pancreatic changes affecting glucose homeostasis in transfusion dependent β-thalassemia (TDT): a short review
por: de Sanctis, Vincenzo, et al.
Publicado: (2021)

The Frequency of Adrenal Insufficiency in Adolescents and Young Adults with Thalassemia Major versus Thalassemia Intermedia in Iran
por: Matin, Sara, et al.
Publicado: (2015)

Severe Liver Iron Concentrations (LIC) in 24 Patients with β-Thalassemia Major: Correlations with Serum Ferritin, Liver Enzymes and Endocrine Complications
por: Kanbour, Ibrahim, et al.
Publicado: (2018)

Growth and endocrine disorders in thalassemia: The international network on endocrine complications in thalassemia (I-CET) position statement and guidelines
por: De Sanctis, Vincenzo, et al.
Publicado: (2013)

Optical coherence tomography findings in patients with transfusion-dependent β-thalassemia
por: Haghpanah, Sezaneh, et al.
Publicado: (2022)

Insulin-like growth factor- I and factors affecting it in thalassemia major
por: Soliman, Ashraf T., et al.
Publicado: (2015)

Alloimmunization among transfusion-dependent thalassemia patients
por: Sadeghian, Mohammad Hadi, et al.
Publicado: (2009)

Quality of life in transfusion-dependent thalassemia patients
por: Alzahrani, Rizqallah A., et al.
Publicado: (2017)

Transfusion Complications in Thalassemia: Patient Knowledge and Perspectives
por: Patterson, Sashoy, et al.
Publicado: (2022)

The Effects of Treatment with Blood Transfusion, Iron Chelation and Hydroxyurea on Puberty, Growth and Spermatogenesis in Sickle Cell Disease (SCD): A short update
por: Soliman, Ashraf T, et al.
Publicado: (2021)

The impact of iron overload in patients with acute leukemia and myelodysplastic syndrome on hepatic and endocrine functions
por: Yassin, Mohamed A, et al.
Publicado: (2018)

Setting for “Normal” Serum Ferritin Levels in Patients with Transfusion-Dependent Thalassemia: Our Current Strategy
por: Spasiano, Anna, et al.
Publicado: (2021)

Hypogonadism in male thalassemia major patients: pathophysiology, diagnosis and treatment
por: De Sanctis, Vincenzo, et al.
Publicado: (2018)

A Short Review on Growth and Endocrine Long-term Complications in Children and Adolescents with β-Thalassemia Major: Conventional Treatment versus Hematopoietic Stem Cell Transplantation
por: Ahmed, Shayma, et al.
Publicado: (2022)

Endocrine and Bone Complications in β-Thalassemia Intermedia: Current Understanding and Treatment
por: Inati, Adlette, et al.
Publicado: (2015)

Ocular findings in patients with transfusion-dependent β-thalassemia in southern Iran
por: Haghpanah, Sezaneh, et al.
Publicado: (2020)

Liver Iron Content (LIC) in Adults with Sickle Cell Disease (SCD): Correlation with Serum Ferritin and Liver Enzymes Concentrations in Trasfusion Dependent (TD-SCD) and Non-Transfusion Dependent (NT-SCD) Patients
por: Yassin, Mohamed, et al.
Publicado: (2017)

Study on effectiveness of transfusion program in thalassemia major patients receiving multiple blood transfusions at a transfusion centre in Western India
por: Shah, Neeraj, et al.
Publicado: (2010)

5588005 IMPACT OF COVID-19 PANDEMIC TO PRE-TRANSFUSION HEMOGLOBIN LEVEL AND FREQUENCY OF TRANSFUSION IN TRANSFUSION-DEPENDENT THALASSEMIA PATIENTS IN INDONESIA
por: Dewi, M.K.D., et al.
Publicado: (2023)

S270: TRANSFUSION INDEPENDENCE AFTER EXAGAMGLOGENE AUTOTEMCEL IN PATIENTS WITH TRANSFUSION-DEPENDENT ΒETA-THALASSEMIA
por: Locatelli, Franco, et al.
Publicado: (2023)

CMR survey in Thalassemia Intermedia patients
por: Meloni, Antonella, et al.
Publicado: (2014)

Hydroxyurea Treatment in Transfusion-Dependent β-Thalassemia Patients
por: Bordbar, Mohammad Reza, et al.
Publicado: (2014)

Ocular abnormalities in multi-transfused beta-thalassemia patients
por: Jafari, Reza, et al.
Publicado: (2015)

Leukocyte telomere length in patients with transfusion-dependent thalassemia
por: Nanthatanti, Nithita, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_f4bsqbm31c5jfq953h4v57mdae